Hospira (HSP) Tops Q3 EPS by 21c; Sees FY EPS at Upper End of Prior Range
Tweet
Share
E-mailGet Alerts HSP Hot Sheet
Price: $89.95 --0%
Financial Fact:
Total operating costs and expenses: 965M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total operating costs and expenses: 965M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Hospira (NYSE: HSP) reported Q3 EPS of $0.74, $0.21 better than the analyst estimate of $0.53. Revenue for the quarter came in at $1.15 billion versus the consensus estimate of $1.08 billion.
Hospira sees FY2014 EPS of $2.40-$2.50, the upper-end of its prior range.
For earnings history and earnings-related data on Hospira (HSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
